TAT 2017
 
Andrés Aguilera
University of Seville, Sevilla, Spain
 
Maria Arcila
Memorial Sloan Kettering Cancer Center, New York, NY, USA
 
Nilofer Azad
Johns Hopkins University, Baltimore, MD, USA
 
Udai Banerji
The Institute of Cancer Research and The Royal Marsden, London, UK
 
Ralf Bargou
Comprehensive Cancer Center Mainfranken, Universitätsklinikum Würzburg, Würzburg, Germany
 
Susan Bates
Columbia University, New York, NY, USA
 
Philippe Bedard
Princess Margaret Cancer Centre, Toronto, Canada
 
Donald A. Bergstrom
Mersana Therapeutics, Cambridge, MA, USA
 
0Eugenia Broude
University of South Carolina, Columbia, SC, United States
 
Laura Rosa Brunet
Immodulon Therapeutics, Uxbridge, United Kingdom
 
Daniel Chen
Genentech, San Francisco, CA, USA
 
Derek Clouthier
Princess Margaret Cancer Centre / University Health Network, Toronto, Canada
 
Esteban Cvitkovic
Medical Oncologist, Paris, France
 
Alexander Eggermont
Institut Gustave Roussy, Villejuif, France
 
0Jean-Marc Egly
IGBMC, CNRS, INSERM, University of Strasbourg, Strasbourg, France
 
Lee Ellis
MD Anderson Cancer Center, Houston, TX, USA
 
Colin Flaveny
Saint Louis University, Saint Louis, MO, USA
 
Lawrence Fong
University of California, San Francisco, CA, USA
 
0Carlos Galmarini
PharmaMar, Madrid, Spain
 
François Ghiringhelli
Centre Georges-François Leclerc, Dijon Cedex, France
 
Giuseppe Giaccone
Georgetown University, Washington, DC, USA
 
Thomas Helleday
SciLifeLab, Stockholm, Sweden
 
0Todd Hembrough
Nantomics, Rockville, MD, USA
 
0Alan Ho
Memorial Sloan Kettering Cancer Center, New York, NY, USA
 
Loan Hoang-Sayag
Cellectis, Paris, France
 
Rachel Humphrey
CytomX Therapeutics, South San Francisco, CA, USA
 
David Hyman
Memorial Sloan Kettering Cancer Center, New York, NY, USA
 
Antoine Italiano
Institut Bergonié, Bordeaux, France
 
Filip Janku
The University Texas MD Anderson Cancer Center, Houston, TX, USA
 
Robert Janssen
Dynavax Technologies, Berkeley, CA, USA
 
Guido Kroemer
University Paris Descartes, Paris, France
 
0Vladimir Lazar
Worldwide Innovative Networking (WIN) Consortium, Villejuif, France
 
Martijn Lolkema
Erasmus MC Cancer Institute, Rotterdam, The Netherlands
 
Christopher Lord
Institute of Cancer Research, London, UK
 
Patricia LoRusso
Yale Cancer Center, New Haven, CT, USA
 
Aurélien Marabelle
Institut Gustave Roussy, Villejuif, France
 
Christophe Massard
Institut Gustave Roussy, Villejuif, France
 
Lawrence D. Mayer
Jazz Pharmaceuticals, Vancouver, Canada
 
Ignacio Melero
University of Navarra, Navarra, Spain
 
Funda Meric-Bernstam
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
 
0Jean-Marie Michot
Institut Gustave Roussy, Villejuif, France
 
Brad Nelson
British Columbia Cancer Agency, Vancouver, Canada
 
David Olmos
Spanish National Cancer Research Centre & Institute of Biomedical Research in Malaga, Madrid, Spain
 
Carlos Paya
Immune Design, South San Francisco, CA, USA
 
Ruth Plummer
Newcastle University, Newcastle upon Tyne, United Kingdom
 
Yves Pommier
National Cancer Institute, Bethesda, MD, USA
 
Sophie Postel-Vinay
Institut Gustave Roussy, Villejuif, France
 
Scott Ribich
Epizyme, Cambridge, MA, USA
 
Vincent Ribrag
Institut Gustave Roussy, Villejuif, France
 
Igor Roninson
University of South Carolina, Columbia, SC, USA
 
Andrew Sawyer
Merrimack Pharmaceuticals, Boston, MA, USA
 
Gary Schwartz
Columbia University, New York, NY, USA
 
Lesley Seymour
Canadian Cancer Trials Group, Kingston, Canada
 
Geoffrey Shapiro
Dana-Farber Cancer Institute, Boston, MA, USA
 
0Akihiko Shimomura
National Cancer Center Hospital, Tokyo, Japan
 
Brian Shuch
Yale University, New Haven, CT, USA
 
Peter Smith
H3 Biomedicine, Arlington, MA, USA
 
Jean-Charles Soria
Institut Gustave Roussy, Villejuif, France
 
0Josep Tabernero
VHIO/Vall d’Hebron University Hospital, Barcelona, Spain
 
Anish Thomas
National Cancer Institute, Bethesda, MD, USA
 
Anthony Tolcher
South Texas Accelerated Research Therapeutics, San Antonio, TX, USA
 
Bertrand Tombal
Cliniques universitaires Saint Luc, Brussels, Belgium
 
0Erica Torchiaro
Candiolo Cancer Institute – FPO IRCCS, Turin, Italy
 
Emile Voest
Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands
 
Jedd Wolchok
Memorial Sloan Kettering Cancer Center, New York, NY, USA
 
0Yi-Long Wu
Guangdong Lung Cancer Institute, Guangdong General hospital, Guangzhou, China
 
Timothy Yap
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
 
Roman Yelensky
Gritstone Oncology, Cambridge, MA, USA